Magnebind 400 Rx
FDA Label NDC 59528-0416

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Nephro-tech, Inc. for the product Magnebind 400 Rx (NDC 59528-0416). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, suggested dosage, contraindications, package label/principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Description

MagneBind 400 Rx is a prescription folic acid supplement with additional nutrients for kidney diaylsis patients. MagneBind 400 Rx is a pink, film-coated, oval shaped tablet.

Suggested Dosage

1-3 tablets with each meal as directed by the physician.

Contraindications

Patients who are hypermagnesemic or who have impaired renal function and are not being dialyzed should not be prescribed MagneBind 400 Rx.

Package Label/Principal Display Panel

59528-0416-05

Rx Only

MagneBind 400 Rx

Mineral/Vitamin Supplement

150 tablets

* Please review the disclaimer below.